The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II clinical trial using anti-CD3 x anti-HER2 bispecific antibody armed activated T cells (HER2 BATs) for HER2-negative (0-2+) metastatic breast cancer.
 
Lawrence G. Lum
Stock and Other Ownership Interests - TransTarget
Consulting or Advisory Role - Rapa Therapeutics
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - I was inventor for "In situ immunization" patent license from Roger Williams Hospital to Transtarget.
 
Archana Thakur
Stock and Other Ownership Interests - NovaRX
 
Zaid S. Al-Kadhimi
No Relationships to Disclose
 
Abhinav Deol
Consulting or Advisory Role - Agios; Kite/Gilead; Novartis
 
Michael S. Simon
No Relationships to Disclose
 
Dana Schalk
No Relationships to Disclose
 
Qin Liu
No Relationships to Disclose
 
Lawrence E. Flaherty
Consulting or Advisory Role - HUYA Bioscience International; Merck/Schering Plough
Travel, Accommodations, Expenses - Merck/Schering Plough